Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy
- 28 February 2012
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 78 (9), 637-643
- https://doi.org/10.1212/wnl.0b013e318248df18
Abstract
Objective: Familial amyloid polyneuropathy (FAP), which is a fatal disorder inherited in an autosomal dominant fashion, is characterized by systemic accumulation of polymerized transthyretin (TTR) in the peripheral nerves and systemic organs. Liver transplantation has become an accepted treatment of this disorder because it stops the major production of amyloidogenic TTR. However, improved survival of transplant patients compared with that of nontransplant patients has not been sufficiently demonstrated. This study investigated whether transplantation improved the long-term outcome of patients by comparing the survival of patients who had transplantations with that of patients who had not had transplantations. Methods: Eighty consecutive patients with FAP Val30Met who visited Kumamoto University Hospital between January 1990 and December 2010 were studied. The transplant group consisted of 37 patients who had a partial hepatic graft via living donor transplantation in Japan or who underwent liver transplantation in Sweden, Australia, or the United States. The nontransplant group consisted of 43 patients with FAP. Survival was evaluated by using Kaplan-Meier analysis, and the difference in survival was examined via the log-rank test. Results: The transplant group had prolonged survival (p < 0.001) compared with the nontransplant group. The estimated probability of survival at 10 years was 56.1% for the nontransplant group vs 100% for the transplant group. Conclusion: Liver transplantation should be considered as an effective treatment in clinical management of patients with FAP Val30Met. Classification of evidence: This study provides Class III evidence that liver transplantation prolongs survival in patients with FAP Val30Met.Keywords
This publication has 31 references indexed in Scilit:
- Transthyretin-related amyloidoses and the heart: a clinical overviewNature Reviews Cardiology, 2010
- Effect of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathyNeurology, 2008
- Transthyretin-Related Familial Amyloidotic PolyneuropathyArchives of Neurology, 2005
- A new diagnostic procedure to detect unknown transthyretin (TTR) mutations in familial amyloidotic polyneuropathy (FAP)Journal of the Neurological Sciences, 2000
- Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type IThe Lancet, 1995
- Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathyJournal of Internal Medicine, 1994
- Transthyretin and Familial Amyloidotic Polyneuropathy.Internal Medicine, 1993
- Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP‐met30)Clinical Genetics, 1991
- Identification of carriers of a variant plasma prealbumin (transthyretin) associated with familial amyloidotic polyneuropathy type I.JCI Insight, 1985
- A PECULIAR FORM OF PERIPHERAL NEUROPATHYBrain, 1952